• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , April 8

THE board of Mumbai-based Sun Pharmaceuticals Industries Ltd has approved an enabling provision to raise funds up to a maximum of $350 million or Rs 1,525 crore.

In a communication to the Bombay Stock Exchange (BSE) on Thursday, the company said it would raise the money by issuing convertible bonds or debentures to local or foreign funds, subject to regulatory and shareholders' approval.

Sun Pharma's EGM is scheduled for May 6.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Grant Thornton opens office in Bangalore

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line